Citigroup’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
168,219
+84,275
| +100% | +$976K | ﹤0.01% | 2061 |
|
|
2025
Q1 | $733K | Sell |
83,944
-35,031
| -29% | -$306K | ﹤0.01% | 2737 |
|
|
2024
Q4 | $1.71M | Buy |
118,975
+103,089
| +649% | +$1.48M | ﹤0.01% | 2236 |
|
|
2024
Q3 | $359K | Sell |
15,886
-8,048
| -34% | -$182K | ﹤0.01% | 3199 |
|
|
2024
Q2 | $466K | Buy |
23,934
+11,395
| +91% | +$222K | ﹤0.01% | 2743 |
|
|
2024
Q1 | $471K | Sell |
12,539
-36,699
| -75% | -$1.38M | ﹤0.01% | 2899 |
|
|
2023
Q4 | $2.76M | Buy |
49,238
+38,287
| +350% | +$2.14M | ﹤0.01% | 1435 |
|
|
2023
Q3 | $452K | Buy |
10,951
+5,317
| +94% | +$219K | ﹤0.01% | 2487 |
|
|
2023
Q2 | $315K | Buy |
5,634
+552
| +11% | +$30.8K | ﹤0.01% | 3004 |
|
|
2023
Q1 | $284K | Sell |
5,082
-16,137
| -76% | -$900K | ﹤0.01% | 2924 |
|
|
2022
Q4 | $773K | Sell |
21,219
-5,313
| -20% | -$194K | ﹤0.01% | 2242 |
|
|
2022
Q3 | $755K | Sell |
26,532
-15,920
| -38% | -$453K | ﹤0.01% | 2307 |
|
|
2022
Q2 | $1.92M | Sell |
42,452
-25,065
| -37% | -$1.13M | ﹤0.01% | 1603 |
|
|
2022
Q1 | $5.14M | Buy |
67,517
+1,388
| +2% | +$106K | ﹤0.01% | 1176 |
|
|
2021
Q4 | $9.85M | Sell |
66,129
-5,467
| -8% | -$814K | 0.01% | 937 |
|
|
2021
Q3 | $10.4M | Sell |
71,596
-20,665
| -22% | -$3.01M | 0.01% | 971 |
|
|
2021
Q2 | $18.1M | Buy |
92,261
+18,372
| +25% | +$3.6M | 0.01% | 786 |
|
|
2021
Q1 | $13.4M | Buy |
73,889
+3,011
| +4% | +$545K | 0.01% | 882 |
|
|
2020
Q4 | $10M | Buy |
70,878
+21,725
| +44% | +$3.08M | 0.01% | 956 |
|
|
2020
Q3 | $6.13M | Buy |
49,153
+45,473
| +1,236% | +$5.67M | ﹤0.01% | 1060 |
|
|
2020
Q2 | $329K | Buy |
3,680
+2,912
| +379% | +$260K | ﹤0.01% | 2810 |
|
|
2020
Q1 | $48K | Buy |
768
+268
| +54% | +$16.8K | ﹤0.01% | 3807 |
|
|
2019
Q4 | $38K | Buy |
+500
| New | +$38K | ﹤0.01% | 4155 |
|